MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients.
Clinical trial NCT05255471 · RECRUITING
Trial details
- NCT number
- NCT05255471
- Sponsor
- National Cancer Institute, Naples
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-21
- Primary completion
- 2028-01-21
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.